According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.37009. At the end of 2014 the company had a P/S ratio of 3.58.
Year | P/S ratio | Change |
---|---|---|
2014 | 3.58 | 22.91% |
2013 | 2.91 | 21.39% |
2012 | 2.40 | 19.06% |
2011 | 2.02 | -14.64% |
2010 | 2.36 | -1.95% |
2009 | 2.41 | 60.42% |
2008 | 1.50 | -50.84% |
2007 | 3.05 | -14.06% |
2006 | 3.55 | -39.43% |
2005 | 5.87 | 45.41% |
2004 | 4.03 | 8.53% |
2003 | 3.72 | -45.63% |
2002 | 6.84 | -9.85% |
2001 | 7.58 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.90 | 64.54% | ๐บ๐ธ USA |
Boston Scientific BSX | 7.50 | 216.33% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.62 | 263.74% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.20 | 161.57% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | 0.7140 | -69.87% | ๐บ๐ธ USA |
CONMED CNMD | 1.85 | -22.04% | ๐บ๐ธ USA |